Google-backed AI drug discovery startup raises $600 million
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Google’s DeepMind Tightens AI Research Release amid AI Competition
AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in ...
GlobalData on MSN3d
Google-backed Isomorphic Labs raises $600m to advance AI drug discovery
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
DATAQUEST3d
Google DeepMind releases TxGemma: Open AI Models for Drug Discovery
Google DeepMind launches TxGemma, open AI models to speed up drug discovery, enhance predictions, and support multi-step ...
Yahoo Finance3d
Google-backed Isomorphic Labs raises $600m to advance AI drug discovery
Since its launch, Isomorphic Labs has focused on using AI to model biological processes and accelerate drug discovery. The company co-developed AlphaFold 3 with Google DeepMind, an AI model ...
pharmaphorum2d
Alphabet's Isomorphic raises $600m for AI drug discovery
Google has said it will release new open-source AI models for drug discovery, TxGemma, through a developers' programme later this month.
The Hindu2d
Google-backed AI drug discovery startup raises $600 million
which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday. Google ...